//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~institution:"Adis International Limited"
~institution:"Europäische Kommission / Generaldirektion Gesundheit und Verbraucher"
~isPartOf:"PharmacoEconomics"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Disease"
Narrow search
Delete all filters
| 3 applied filters
Year of publication
From:
To:
Subject
All
Adalimumab
1
Certolizumab-pegol
1
Cost-utility
1
Disease-modifying-antirheumatics
1
Errata
1
Etanercept
1
Golimumab
1
Infliximab
1
Methotrexate
1
Rheumatoid-arthritis
1
Tumour-necrosis-factor-alpha-inhibitors
1
more ...
less ...
Online availability
All
Undetermined
1
Type of publication
All
Article
1
Language
All
Undetermined
1
Institution
All
Adis International Limited
Europäische Kommission / Generaldirektion Gesundheit und Verbraucher
Published in...
All
PharmacoEconomics
Disease Management and Health Outcomes
41
Orphanet Report Series : Rare Diseases collection, November 2010
1
Source
All
RePEc
1
Showing
1
-
1
of
1
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Erratum
Adis International Limited
- In:
PharmacoEconomics
30
(
2012
)
11
,
pp. 1096-1096
Persistent link: https://www.econbiz.de/10010579448
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->